Secondary Logo

Journal Logo



Pharmacogenetics, 2001, 11:417–427

Re: Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity. The following corrections should be noted.

Page 418 Line 18 under ‘Sequencing analysis'. ‘... were sequenced using Sequenase T7 DNA polymerase from Amersham Pharmacia Biotech (Uppsala, Sweden) with a-35S dATP labellling.’ Should read ‘... were sequenced by terminator cycle sequencing using Thermosequenase with α 33P-ddNTP labelling (Amersham Pharmacia Biotech, Uppsala, Sweden).'

Page 419 Table 1. The first base in the 5′ end of primer G1749C should be a C instead of a T.

Page 420 First column. Lines 14 and 15 should read ‘... α 32P-labelled ...'.

Page 421 First column. Line 16 should read ‘... for 15 min followed by 8 min centrifugation ...’ instead of ‘... as above followed by 8 min centrifugation ...'.

© 2001 Lippincott Williams & Wilkins, Inc.